The FDA has approved Tevimbra (tislelizumab-jsgr) for a second indication: in combination with platinum and fluoropyrimidine-based…
Continue Reading
The FDA has approved Tevimbra (tislelizumab-jsgr) for a second indication: in combination with platinum and fluoropyrimidine-based…
Continue Reading